期刊文献+

高血压病左室肥厚患者血浆脑钠肽的变化 被引量:4

Plasma levels of brain natriuretic peptides in hypertension patients with left ventricular hypertrophy
下载PDF
导出
摘要 目的:研究高血压病左心室肥厚患者血浆脑钠肽水平的变化,探讨高血压病患者肥厚的左心室心肌细胞内分泌的病理生理改变。方法:入选120例左室射血分数正常范围的高血压病患者,其中64例伴左心室肥厚,56例不伴左心室肥厚;另选50例健康者为对照组。放射免疫法测定血浆脑钠肽水平。结果:左心室肥厚组血浆脑钠肽水平明显高于不伴左心室肥厚组,不伴左心室肥厚组和对照组血浆脑钠肽水平差异无统计学意义。结论:高血压病伴有左心室肥厚的患者在心功能失代偿前,心肌细胞已出现脑钠肽的代偿性合成和分泌增加。  Objective To investigate the dynamic changes of brain natriuretic peptides in essential hypertension patients with 1eft ventricular hypertrophy.Methods One hundred and twenty consecutive essential hypertension patients were divided into LVH group(64 patients with 1eft ventricular hypertrophy)and NLVH group(56 patients without 1eft ventricular hypertrophy).The plasma 1evels of brain natriuretic peptides were measured with radio-immunoassay and immunoradiometric assay.Other 50 healthy persons with normal blood pressure served as controls.Results The plasma levels of brain natriuretic peptides were significantly elevated in LVH group compared with NLVH group(P〈0.05).The elevation of plasma brain natriuretic peptides was shown when the ejection fraction in these 1eft ventricular hypertrophy patients was in the normal range.There was no statistic difference in brain natriuretic peptides between NLVH group and normal controls(P〉0.05).Conclusion Brain natriuretic peptides are elevated before 1eft ventricular hypertrophy is progressed into cardiac dysfunction.
作者 谈俊 臧敏华
出处 《实用诊断与治疗杂志》 2007年第11期835-837,共3页 Journal of Practical Diagnosis and Therapy
关键词 原发性高血压病 左心室肥厚 脑钠肽 Essential hypertension left ventricular hypertrophy brain natriuretic peptide
  • 相关文献

参考文献11

  • 1Stanek B, Frey B, Hulsmann M, et al. Prognostic evaluation of neurohumoral plasma levels before and during B-blocker therapy in advanced left ventricular dysfunction[J]. J Am Coll Cardiol, 2001, 38(2): 436-442. 被引量:1
  • 2曹国良,乔永芳,戴蓉芳.中美欧高血压指南之比较[J].医学与哲学,2005,26(5):46-47. 被引量:43
  • 3Sahn D J, DeMaria A, Kisslo J, et al. The Committee on M- Mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography Results of survey of echocardiographic measurements [ J ]. Circulation, 1978, 58 (10): 1072-1083. 被引量:1
  • 4Devereux R B, Alonso D R, Lutas E M, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings[J]. Am J Caridol, 1986, 57(3): 450-458. 被引量:1
  • 5Beck-da-Silva L, Rohde L E, Goldraich L, et al. Clinical findings, natriuretic peptides, and echocardiography : integrating tools to optimize heart failure management [J]. Congest Heart Fail, 2007, 13(3): 158-163. 被引量:1
  • 6Miller W L, Hartman K A, Burritt M F, et al. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: Differences between ischemic and dilated cardiomyopathies [J]. Clin Cardiol, 2007, 30(5): 245-250. 被引量:1
  • 7Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system . Cardiovascular Research [J]. 2001, 51(2): 489-494. 被引量:1
  • 8Vesely D L. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer [ J ]? Clin Exp Pharmacol Physiol, 2006, 33 (3): 169-176. 被引量:1
  • 9Suzuki M, Yamamoto K, Watanabe S, et al. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension[J]. Med, 2000, 108(3): 627-633. 被引量:1
  • 10l.uchner A, Burnett Jr J C, Jougasaki M, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population[J]. J Hypertens, 2000, 18(8): 1121-1128. 被引量:1

二级参考文献19

  • 1刘玲,郭雷生,王保振,王丽华,崔天祥,李莉.内源性一氧化碳对高血压大鼠血压的长期影响[J].实用诊断与治疗杂志,2004,18(4):276-277. 被引量:2
  • 2孙盘丽,贾合磊.盐酸贝那普利对高血压患者左室肥厚的影响[J].实用诊断与治疗杂志,2005,19(2):132-133. 被引量:6
  • 3刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 4Devereux R B, Alonso D R, Lutas, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy finding[J]. Am J Cardiol,1986,57(6):450. 被引量:1
  • 5Weber K T, Brilla C G. Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system[J]. Circulation,1991,83(6) : 1849. 被引量:1
  • 6Sun Y, Ramires FJA, Weber K T. Fibrosis of artria and great vessels in response to angiotensin Ⅱ or aldosterone system[J].Circulation Res,1997,35(1):138. 被引量:1
  • 7Eleftheriades E G, Durand J B, Fergusen A G, et al. Regulation of procollagen metabolism the pressure overloads rat heart[J]. J Clin Invest,1993,91 (3) : 1113. 被引量:1
  • 8Kolpakov V, Gordon D, Kulik T J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells[J]. Cir Res,1995,76(2):305. 被引量:1
  • 9Koj M, Shiojima I, Yamazaki T, et al. Angiotesin Ⅱ receptor antagonist Tcv-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular sig naling pathway of strotch-mediatd cardiomyocyte hypertrophy in vitro[J]. Circulation, 1994,89 (5):2204. 被引量:1
  • 10Timmermans P B, Wong P C, Chiu A T, et al. Angiotensin Ⅱ receptors and angiotensin Ⅱ receptor antagonists[J]. Pharmacol Ther, 1993,45 (2):205. 被引量:1

共引文献52

同被引文献40

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部